CIK 0001711754 · Non-accelerated filer<br>Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 475205835
- Phone
- 8589643720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | Moss David J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −130,000 | 0 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −223,000 | 0 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +223,000 | 223,000 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −160,000 | 0 | ||
| 2025-11-18 | Moss David J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −400,000 | 0 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −180,000 | 0 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −104,000 | 0 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +104,000 | 104,000 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −140,000 | 0 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −100,000 | 0 | ||
| 2025-11-18 | Lowdell Mark William Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 |
Page 3 of 11 · 216 trades